Trial Profile
Effect and safety of Baloxavir Marboxil in children with influenza: multicenter randomized controlled study
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 11 May 2020
Price :
$35
*
At a glance
- Drugs Baloxavir-marboxil (Primary) ; Laninamivir (Primary) ; Oseltamivir (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- 10 May 2020 Planned End Date changed from 30 Sep 2019 to 31 May 2019.
- 10 May 2020 Status changed from recruiting to active, no longer recruiting.
- 09 Jan 2019 Status changed from not yet recruiting to recruiting.